Cangene hires new vice president of R&D

Toronto, ON and Winnipeg, MB – Biopharmaceutical company Cangene says it has hired Dr Grant McClarty as vice president of research and development to fill the position vacated by Dr Wendy Johnson who is on a long-term medical leave of absence.

Before joining Cangene, Dr McClarty was director of biomedical research at the National Microbiology Laboratory, a division of the Public Health Agency of Canada, for six years. The NML is located in Winnipeg, MB and is Canada’s leading public health infectious disease laboratory; it is responsible for the identification, control and prevention of infectious diseases.

Dr McClarty has a PhD in microbiology from the University of Manitoba where he is currently a professor in the department of medical microbiology and infectious diseases. He brings extensive experience working in the infectious disease arena, with special interest in chlamydia research, host-parasite interactions and bacterial genomics.

“We welcome Grant to our senior management team. We are extremely pleased that someone with his background was available and believe that he is an excellent addition to our research and development groups,” said Dr John Langstaff, Cangene’s president and CEO.